Previous 10 | Next 10 |
AtriCure (ATRC): Q1 Non-GAAP EPS of -$0.32 beats by $0.04; GAAP EPS of -$0.38 beats by $0.01.Revenue of $59.28M (+11.4% Y/Y) beats by $3.22M.Press Release For further details see: AtriCure EPS beats by $0.04, beats on revenue
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2021 financial results. “Our growth in the first quarter is a testament of our team’s strong execut...
AtriCure (ATRC) has named B. Kristine (Kris) Johnson as its new Board Chair. The current chair Scott Drake and another director Mark Lanning are not standing for reelection at the end of their terms in May 2021, the company said.A Board member at the company since 2017, Ms. Johnson sits ...
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that B. Kristine (Kris) Johnson has been named Board Chair. In addition, the Company announced that Scott Drake and Mark Lanning wi...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its first quarter 2021 financial results on Tuesday, April 27, 2021. AtriCure will host a confer...
The following slide deck was published by AtriCure, Inc. in conjunction with this event. For further details see: AtriCure (ATRC)Presents At Oppenheimer 31st Annual Healthcare Conference - Slideshow
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming Oppenheimer 31 st Annual Healthcare Conference. A...
Image source: The Motley Fool. AtriCure Inc (NASDAQ: ATRC) Q4 2020 Earnings Call Feb 23, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: AtriCure Inc (ATRC) Q4 2020 Earnings Call Transcript
AtriCure, Inc. (ATRC) Q4 2020 Earnings Conference Call February 23, 2021 16:30 ET Company Participants Lynn Lewis - Gilmartin Group Mike Carrel - President & Chief Executive Officer Angie Wirick - Chief Financial Officer Conference Call Participants Mike Matson - Needham & Company Mat...
AtriCure (ATRC): Q4 Non-GAAP EPS of -$0.18 beats by $0.07; GAAP EPS of -$0.42 misses by $0.13.Revenue of $57.73M (-5.9% Y/Y) misses by $0.23M.Shares -5.03%.Press Release For further details see: AtriCure EPS beats by $0.07, misses on revenue
News, Short Squeeze, Breakout and More Instantly...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it has received regulatory approval from the National Medical Products A...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its second quarter 2024 financial results on Tuesday, Ju...